On August 20th local time, according to Scientific American magazine, Vertex Pharmaceuticals, a pharmaceutical company in the United States, has developed a new painkiller that can reduce the level of acute pain by about half and is non-addictive. On July 30, 2024, Vertex announced that the U.S. Food and Drug Administration (FDA) has accepted the new drug application for this medication and has granted it priority review qualification. The medication is called VX-548 and is used to treat moderate to severe acute pain. If it is successfully launched, it will be the first non-opioid acute pain medication in twenty years, which is a milestone new drug. (The Paper)
使急性疼痛降半，20年来首个无成瘾风险止痛药递交上市申请
The new painkiller developed by Vertex Pharmaceuticals (Vertex) in the United States can reduce the level of acute pain by about half and has no addiction risk. On July 30, 2024, Vertex announced that the U.S. Food and Drug Administration (FDA) has accept
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated